Kwang S. Lee
Keine laufenden Positionen mehr
Profil
Kwang S.
Lee worked as an Associate Director of Financial Planning & Analysis at Perlegen Sciences, Inc. He then worked as a Senior Director of Finance at Bayhill Therapeutics, Inc. from 2007 to 2011.
Prior to that, he was a Controller & Finance Director at MeeVee, Inc. and a Senior Financial Analyst at Genitope Corp.
He also served as Secretary, Chief Accounting Officer & VP-Finance at Galena Biopharma, Inc. Mr. Lee received his undergraduate degree from San Jose State University and California Polytechnic State University (San Luis Obispo).
Ehemalige bekannte Positionen von Kwang S. Lee
| Unternehmen | Position | Ende |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Finanzdirektor/CFO | 02.07.2012 |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Finanzdirektor/CFO | 01.10.2011 |
| GENITOPE CORPORATION | Corporate Officer/Principal | - |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | - |
MeeVee, Inc.
 MeeVee, Inc. Internet Software/ServicesTechnology Services MeeVee, Inc. operates an online guide for local television listings. It tracks favorite channels, TV shows, actors, directors, and hobbies and shows on the TV. The company was founded by Gil Dudkiewicz and Jonathan Barker in 2000 and is headquartered in Burlingame, CA. | Finanzdirektor/CFO | - |
Ausbildung von Kwang S. Lee
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
| San Jose State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
MeeVee, Inc.
MeeVee, Inc. Internet Software/ServicesTechnology Services MeeVee, Inc. operates an online guide for local television listings. It tracks favorite channels, TV shows, actors, directors, and hobbies and shows on the TV. The company was founded by Gil Dudkiewicz and Jonathan Barker in 2000 and is headquartered in Burlingame, CA. | Technology Services |
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
